文献速递腹部MR

钆塞酸二钠增强MRI对多中心性肝细胞癌术后结局的预后因素

Prognostic factors of gadoxetic acid-enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma.
PubMed 文献 · Eur Radiol · 2020-11-04

本回顾性研究纳入54例共120个多中心性肝细胞癌手术切除患者,评估术前钆塞酸二钠增强MRI的动脉期高强化和LI-RADS分类等影像因素及临床病理因素对无病生存和总生存的预测价值。结果显示微血管侵犯和三个及以上病灶是不良无病生存的独立预测因素,微血管侵犯是唯一与总生存相关的因素,而影像参数与术后结局无关。

要点

  • 微血管侵犯和三个及以上肝细胞癌灶与更短的无病生存独立相关。
  • 微血管侵犯是唯一与总生存相关的独立因素。
  • 术前MRI的动脉期高强化和LI-RADS分类与术后生存无关。

诊断标准与关键数值

  • 微血管侵犯的存在预测更短的无病生存(p = 0.003)。
  • 三个及以上肝细胞癌灶预测更短的无病生存(p = 0.013)。
  • 微血管侵犯是唯一预测总生存的统计学显著参数(p = 0.023)。
  • 同时存在微血管侵犯和三个及以上肝细胞癌灶的患者无病生存最短。
  • 伴有动脉期高强化或LR-5/M分类的肝细胞癌数量与生存无关。

临床应用与阅片要点

  • 术前钆塞酸二钠增强MRI评估多中心性肝细胞癌时,动脉期高强化和LI-RADS分类未显示与术后无病生存或总生存相关。
  • 微血管侵犯和三个及以上病灶数量与更差的无病生存相关,微血管侵犯与更差的总生存相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The primary aim of this study was to determine the clinical and histopathological prognostic factors for patients who underwent surgical resection of multiple hepatocellular carcinomas (HCCs) of multicentric occurrence. The secondary aim of this study was to evaluate whether specific imaging-related factors, including arterial phase hyperenhancement (APHE) and the LI-RADS category of each lesion on gadoxetic acid-enhanced MRI, would provide additional prognostic information about multicentric HCCs.

METHODS: In this retrospective study, 54 patients with 120 multicentric HCCs were diagnosed by surgical resection at a single tertiary hospital between 2009 and 2014. Two independent readers evaluated patients' preoperative gadoxetic acid-enhanced MR images and recorded APHE and LI-RADS category for each HCC, with discrepancies resolved through consensus sessions if necessary. Potential clinicopathologic and imaging parameters for predicting disease-free survival (DFS) and overall survival (OS) were analyzed using Cox regression analysis.

RESULTS: Presence of microvascular invasion (MVI) (p = 0.003) and of three or more HCCs (p = 0.013) were both independent predictors of a shorter DFS. Patients with concurrent MVI and three or more HCCs had the shortest DFS. MVI was the only statistically significant parameter (p = 0.023) predicting OS. The number of HCCs with APHE or LR-5/M category was not associated with survival.

CONCLUSIONS: Presence of MVI and of three or more HCCs were associated with poorer outcomes after surgical resection of multicentric HCCs. Imaging parameters on gadoxetic acid-enhanced MRI such as APHE or LI-RADS category were not associated with postsurgical outcomes.

KEY POINTS: • Patients with three or more hepatocellular carcinomas showed worse disease-free survival than those with two hepatocellular carcinomas after surgical resection. • Microvascular invasion was the only significant factor to affect both the disease-free and overall survivals of patients after surgical resection of multicentric hepatocellular carcinomas. • Preoperative MRI findings related to multicentric hepatocellular carcinomas such as arterial phase hyperenhancement and LI-RADS category of lesions did not provide significant prognostic information.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kim SS, Lee S, Kim MJ, et al. Prognostic factors of gadoxetic acid-enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma. Eur Radiol. 2020. PMID: 33146795. doi:10.1007/s00330-020-07419-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。